HTG is a life science company advancing precision medicine by leveraging its innovative transcriptome-wide profiling technology to develop profiling diagnostics and novel drug candidates to determine the right therapy for the right patient.
News & Events
HTG Molecular Diagnostics Announces Certain Preliminary 2021Unaudited Financial Results
Preliminary full year 2021 unaudited revenue of $8.9 million Cash, cash equivalents and short-term marketable securities of $21.9 million as of December 31, 2021 TUCSON, Ariz. , Jan. 06, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose…
- Category:
- Press Releases
HTG Completes HTP Product Next-Phase Development Milestone
Expands Potential Market and Study Opportunities for HTG Transcriptome Panel TUCSON, Ariz. , Dec. 22, 2021 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology,…
- Category:
- Press Releases
HTG Expands Therapeutics Scientific Advisory Board With Addition of Dr. Jerald Radich
Renowned Physician-Scientist Brings Significant Expertise as a Pioneer in the Fields of Leukemia Research and Molecular Genetics TUCSON, Ariz. , Dec. 16, 2021 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its…
- Category:
- Press Releases
Publications
Read white papers or journal publications and view other scientific content.
Careers at HTG
At HTG, we are always looking for talented individuals to help us deliver our next-generation sequencing-based products throughout the world.
New Careers
Director, Scientific Collaborations
Page last updated November 09, 2021